Completed Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers NCT03452332 Conditions Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma, Advanced Vulvar Carcinoma, +50 more Locations UT Southwestern/Simmons Cancer Center-Dallas — Dallas, Texas, United States M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
Active, Not Recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors NCT03074513 Conditions Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +63 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
